Q2 2025 Aker Biomarine ASA Earnings Call Transcript

Author's Avatar
Jul 11, 2025

Jul 11, 2025 / 07:00AM GMT
Matts Johansen - Aker Biomarine ASA - Chief Executive Officer

Good morning and welcome to the presentation of Aker BioMarine's highlights and financials for the second-quarter 2025 where, myself, Matts Johansen, the CEO; and the CFO, Katrine Klaveness, will take you through today's presentation. After we are presented, we will host a Q&A session, and you can already now start to send in questions to IR at akerbiomarine.com.

The second quarter now is the ninth quarter in the row where I can stand here and say that we are delivering growth for the company as a whole. We delivered 12% growth over the same quarter last year at $55.3 million and improved the EBITDA 41%, up to $13.6 million EBITDA.

It was driven by good performance in our main two segments, Human Health Ingredients that delivered 15% growth to $29.2 million of revenue and $13.9 million of EBITDA, up 28% from the same quarter last year. Also, Consumer Health Products delivered well in the quarter. $27.1 million of revenue, 9% up compared to the same quarter last year, and $1.6 million of EBITDA.

Emerging Business,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot